z-logo
open-access-imgOpen Access
How Does the NPM1 Mutant Induce Leukemia?
Author(s) -
Paolo Sportoletti
Publication year - 2011
Publication title -
pediatric reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.297
H-Index - 19
ISSN - 2036-7503
DOI - 10.4081/pr.2011.s2.e6
Subject(s) - npm1 , mutant , nucleophosmin , biology , myeloid leukemia , leukemia , cancer research , mutation , loss function , gene , genetics , phenotype , karyotype , chromosome
NPM1 is the most frequently mutated gene in AML and the role of the NPM1 mutant in acute myeloid leukemia along with its leukemogenic potential are still under investigation. NPM1 genetic alterations can contribute to leukemogenesis through the direct oncogenic effect of the mutant protein and the concomitant loss of one functional allele. Npm1 loss determines tumor development in the mouse while in human NPM1 maps in a chromosomal region frequently loss in myelodysplastic syndrome (MDS). The NPM1 mutant cytoplasmic delocalization in leukemic blasts alters multiple cellular pathways through either loss or gain of function effects on different protein partners. Here we discuss the most relevant studies on the role of the NPM1 molecule in hematological malignancies and both in vitro and in vivo studies that are trying to elucidate the way by which the NPM1 mutation induces leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom